GlassScriptPhysician profile
Christine C Lin
NPI 1497703797
$1,272.90
in general payments reported to CMS, 2019-2025
14 companies · $281 in 2025
The $281 reported for 2025 was less than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $394 · 2020: $35.83 · 2021: $52.62 · 2022: $72.71 · 2023: $182 · 2024: $254 · 2025: $281.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $717.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $717.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $522.90 | 2019-2024 | |
| E.R. Squibb & Sons, L.L.C. | $323.38 | 2023-2025 | Sotyktu |
| Janssen Scientific Affairs, LLC | $187.86 | 2025 | Tremfya |
| Springworks Therapeutics, INC. | $46.14 | 2025 | Gomekli |
| Krystal Biotech INC | $27.53 | 2023 | Vyjuvek |
| Kyowa Kirin, INC. | $24.55 | 2024 | Poteligeo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.30 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $23.73 | 2019 | |
| Merck Sharp & Dohme LLC | $23.57 | 2019 | |
| Pierre Fabre Pharmaceuticals, INC. | $18.17 | 2019 | |
| Hologic Sales and Service, LLC | $17.72 | 2024 | Localizer, Trident Specimen Radiography System, Celero-12 |
| Ucb, INC. | $17.29 | 2019 | |
| Sun Pharmaceutical Industries INC. | $15.76 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christine Lin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.